Literature DB >> 21815785

Impact of GOS misclassification on ordinal outcome analysis of traumatic brain injury clinical trials.

Juan Lu1, Anthony Marmarou, Kate L Lapane.   

Abstract

This study extends our previous investigation regarding the effect of nondifferential dichotomous Glasgow Outcome Scale (GOS) misclassification in traumatic brain injury (TBI) clinical trials to the effect of GOS misclassification on ordinal analysis in TBI clinical trials. The impact of GOS misclassification and ordinal outcome analysis was explored via probabilistic sensitivity analyses using TBI patient datasets from the IMPACT database (n = 9205). Three patterns of misclassification were explored given the pre-specified misclassification distributions. For the random pattern, we specified a trapezoidal distribution (minimum: 80%, mode: 85%, and 95%, maximum: 100%) for both sensitivity and specificity; for the upward pattern, the same trapezoidal distribution for sensitivity but with a perfect specificity; and for the downward pattern, the same trapezoidal distribution for specificity but with a perfect sensitivity. The conventional 95% confidence intervals and simulation intervals, which accounts for the misclassification and random errors together, were reported. The results showed that given the specified misclassification distributions, the misclassification with a random or upward pattern would have caused a slightly underestimated outcome in the observed data. However, the misclassification with a downward pattern would have resulted in an inflated estimation. Thus the sensitivity analysis suggests that the nondifferential misclassification can cause uncertainties on the primary outcome estimation in TBI trials. However, such an effect is likely to be small when ordinal analysis is applied, compared with the impact of dichotomous GOS misclassifications. The result underlines that the ordinal GOS analysis may gain from both statistical efficiency, as suggested by several recent studies, and a relatively smaller impact from misclassification as compared with conventional binary GOS analysis.

Entities:  

Mesh:

Year:  2011        PMID: 21815785      PMCID: PMC3303101          DOI: 10.1089/neu.2010.1746

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  18 in total

1.  Semi-automated sensitivity analysis to assess systematic errors in observational data.

Authors:  Timothy L Lash; Aliza K Fink
Journal:  Epidemiology       Date:  2003-07       Impact factor: 4.822

2.  A method to automate probabilistic sensitivity analyses of misclassified binary variables.

Authors:  Matthew P Fox; Timothy L Lash; Sander Greenland
Journal:  Int J Epidemiol       Date:  2005-09-19       Impact factor: 7.196

3.  IMPACT database of traumatic brain injury: design and description.

Authors:  Anthony Marmarou; Juan Lu; Isabella Butcher; Gillian S McHugh; Nino A Mushkudiani; Gordon D Murray; Ewout W Steyerberg; Andrew I R Maas
Journal:  J Neurotrauma       Date:  2007-02       Impact factor: 5.269

4.  Use of ordinal outcomes in vascular prevention trials: comparison with binary outcomes in published trials.

Authors:  Philip M W Bath; Chamila Geeganage; Laura J Gray; Timothy Collier; Stuart Pocock
Journal:  Stroke       Date:  2008-07-31       Impact factor: 7.914

5.  Reliability of postal questionnaires for the Glasgow Outcome Scale.

Authors:  J T L Wilson; P Edwards; H Fiddes; E Stewart; G M Teasdale
Journal:  J Neurotrauma       Date:  2002-09       Impact factor: 5.269

6.  A simulation study evaluating approaches to the analysis of ordinal outcome data in randomized controlled trials in traumatic brain injury: results from the IMPACT Project.

Authors:  Gillian S McHugh; Isabella Butcher; Ewout W Steyerberg; Anthony Marmarou; Juan Lu; Hester F Lingsma; James Weir; Andrew I R Maas; Gordon D Murray
Journal:  Clin Trials       Date:  2010-02       Impact factor: 2.486

7.  Assessment of outcome after severe brain damage.

Authors:  B Jennett; M Bond
Journal:  Lancet       Date:  1975-03-01       Impact factor: 79.321

8.  Agreement between physicians on assessment of outcome following severe head injury.

Authors:  A I Maas; R Braakman; H J Schouten; J M Minderhoud; A H van Zomeren
Journal:  J Neurosurg       Date:  1983-03       Impact factor: 5.115

9.  Effects of Glasgow Outcome Scale misclassification on traumatic brain injury clinical trials.

Authors:  Juan Lu; Gordon D Murray; Ewout W Steyerberg; Isabella Butcher; Gillian S McHugh; Hester Lingsma; Nino Mushkudiani; Sung Choi; Andrew I R Maas; Anthony Marmarou
Journal:  J Neurotrauma       Date:  2008-06       Impact factor: 5.269

10.  Observer variation in the assessment of outcome in traumatic brain injury: experience from a multicenter, international randomized clinical trial.

Authors:  J T Lindsay Wilson; Frans J A Slieker; Valerie Legrand; Gordon Murray; Nino Stocchetti; Andrew I R Maas
Journal:  Neurosurgery       Date:  2007-07       Impact factor: 4.654

View more
  5 in total

1.  Glasgow Outcome Scale Measures and Impact on Analysis and Results of a Randomized Clinical Trial of Severe Traumatic Brain Injury.

Authors:  Jose-Miguel Yamal; H Julia Hannay; Shankar Gopinath; Imoigele P Aisiku; Julia S Benoit; Claudia S Robertson
Journal:  J Neurotrauma       Date:  2019-05-23       Impact factor: 5.269

2.  ABCG2 c.421C>A Is Associated with Outcomes after Severe Traumatic Brain Injury.

Authors:  Solomon M Adams; Yvette P Conley; Dianxu Ren; David O Okonkwo; Ava M Puccio; C Edward Dixon; Robert S B Clark; Patrick M Kochanek; Philip E Empey
Journal:  J Neurotrauma       Date:  2017-09-19       Impact factor: 5.269

Review 3.  The Risk for Lung Cancer Incidence with Calcium Channel Blockers: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Victoria Rotshild; Laurent Azoulay; Majd Zarifeh; Reem Masarwa; Bruria Hirsh-Raccah; Amichai Perlman; Mordechai Muszkat; Ilan Matok
Journal:  Drug Saf       Date:  2018-06       Impact factor: 5.606

Review 4.  Embracing failure: What the Phase III progesterone studies can teach about TBI clinical trials.

Authors:  Donald G Stein
Journal:  Brain Inj       Date:  2015-08-14       Impact factor: 2.311

5.  Added Value of a Blinded Outcome Adjudication Committee in an Open-Label Randomized Stroke Trial.

Authors:  Nadinda A M van der Ende; Bob Roozenbeek; Olvert A Berkhemer; Peter J Koudstaal; Jelis Boiten; Ewoud J van Dijk; Yvo B W E M Roos; Robert J van Oostenbrugge; Charles B L M Majoie; Wim van Zwam; Hester F Lingsma; Aad van der Lugt; Diederik W J Dippel
Journal:  Stroke       Date:  2021-10-05       Impact factor: 7.914

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.